← FDA DRUG APPROVALS

FDA ANDA · ANDA087723

ANGIOVIST 370

Sponsor: BAYER HLTHCARE

APPLICATION
ANDA087723
TYPE
ANDA
ORIGINAL APPROVAL
1982-09-23
LATEST ACTION
1989-08-23
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ANGIOVIST 370Discontinued
DIATRIZOATE MEGLUMINE 66%, DIATRIZOATE SODIUM 10% · INJECTABLE · INJECTION

Approval history

1989-08-23Labeling · Supplement 15AP
1982-09-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →